Development of liposomes using formulation by design: Basics to recent advances.

Chem Phys Lipids

Pharmaceutics Research Projects Laboratory, Department of Pharmaceutical Sciences, Dr. Hari singh Gour University, 470003, Sagar, M.P., India. Electronic address:

Published: November 2019

In couple of decennia, optimization tactics for drug delivery systems have been explored widely employing Design of Experiments (DoE) for desired outcomes to overcome drawbacks of "One Factor at a Time (OFAT)"conventional technique.. To pace with advances in computational approaches engaged in research domain, QbD-based tactic i.e. Formulation by Design (FbD) is under extensive investigation by budding scientists for better know-how of the product and process development for an unequivocal universal acceptation. Like other vesicular drug carriers, liposomes also demand robustness and reproducibility to scale up at industrial outset. Based on said outlook, this review focuses on the fundamentals and methodologies like Central Composite, Simplex Mixture, Box-Behnken, Factorial, Taguchi, Simplex Centroid, d-optimal, Placket Burman, and Orthogonal array with special reference to applications of FbD in the development of liposomes.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.chemphyslip.2019.03.017DOI Listing

Publication Analysis

Top Keywords

development liposomes
8
formulation design
8
liposomes formulation
4
design basics
4
basics advances
4
advances couple
4
couple decennia
4
decennia optimization
4
optimization tactics
4
tactics drug
4

Similar Publications

Background: Most patients with prostate cancer inevitably progress to castration-resistant prostate cancer (CRPC), at which stage chemotherapeutics like docetaxel become the first-line treatment. However, chemotherapy resistance typically develops after an initial period of therapeutic efficacy. Increasing evidence indicates that cancer stem cells confer chemotherapy resistance via exosomes.

View Article and Find Full Text PDF

Ligustilide, a phthalide compound extracted from Umbelliferae plants such as Angelica sinensis and Ligusticum chuanxiong, has been proven to possess various pharmacological activities, such as anti-inflammatory, anti-tumor, anti-atherosclerosis, anti-ischemic stroke injury, and anti-Alzheimer's disease properties. In recent years, it has shown great potential, particularly in the treatment of locomotor system diseases. Studies have shown that ligustilide has significant therapeutic effects on various locomotor system diseases, including osteoporosis, osteoarthritis, femoral head necrosis, osteosarcoma, and muscle aging and injury.

View Article and Find Full Text PDF

[Research progress in acupoint administration of new dosage forms of traditional Chinese medicine preparations for rheumatoid arthritis].

Zhongguo Zhong Yao Za Zhi

December 2024

College of Pharmaceutical Sciences, Guizhou University of Traditional Chinese Medicine Guiyang 550025, China National Engineering Technology Research Center for Miao Medicine Guiyang 550025, China Guizhou Engineering Technology Research Center for Processing and Preparation of Traditional Chinese Medicine and Ethnic Medicine Guiyang 550025, China.

The conventional acupoint therapy for rheumatoid arthritis often uses traditional Chinese medicine preparations in the dosage forms of powder, ointment, and paste. However, these dosage forms have obvious drawbacks, such as low transdermal absorption, strong skin irritation, and easy detachment. Creating a traditional Chinese medicine acupoint therapy characterized by high penetration, low toxicity, low irritation, and convenient administration is of great significance.

View Article and Find Full Text PDF

Promotion of Triple Negative Breast Cancer Immunotherapy by Combining Bioactive Radicals with Immune Checkpoint Blockade.

Acta Biomater

January 2025

Institute of Breast Health Medicine, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, Sichuan, China, 610041. Electronic address:

Although immunotherapy has revolutionized clinical cancer treatment, the efficacy is limited due to the lack of tumor-associated antigens (TAAs) and the presence of compensatory immune checkpoints. To overcome the deficiency, a nano-system loaded with ozone and CD47 inhibitor RRx-001 is designed and synthesized. Upon irradiation, reactive oxygen species (ROS) generated from ozone reacts with nitric oxide (NO) metabolized from RRx-001 to form reactive nitrogen species (RNS), which presents a much stronger cell-killing ability than ROS.

View Article and Find Full Text PDF

Radiopaque hydrogel-in-liposomes towards theranostic applications for malignant tumors.

Biomed Pharmacother

January 2025

College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 08826, Republic of Korea; Natural Products Research Institute, Seoul National University, Seoul 08826, Republic of Korea. Electronic address:

A radiopaque hydrogel-in-liposome (RHL) system was developed for micro-computed tomography (μCT) imaging of tumor tissue and simultaneous delivery of a cytotoxic agent. Iopamidol (IPD) and doxorubicin (DOX) were incorporated as the CT contrast and anti-cancer agents, respectively. The presence of a polyethylene glycol hydrogel core in the liposomes was confirmed via attenuated total reflectance Fourier transform infrared, proton nuclear magnetic resonance, and selective solvent extraction.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!